UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear Palsy

Frontiers in neurology, 2021-09, Vol.12, p.736784-736784

2021

Link zum Volltext

Verfügbarkeit prüfen

Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept

CNS oncology, , Vol.5 (2), p.101-108

Link zum Volltext

Verfügbarkeit prüfen

Newly Diagnosed Glioblastoma in Elderly Patients

Current oncology reports, 2022-03, Vol.24 (3), p.325-334

2022

Link zum Volltext

Verfügbarkeit prüfen

Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report

Personalized medicine, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

An atypical presentation of primary central nervous system lymphoma: A case report

Medicine (Baltimore), 2020-09, Vol.99 (38), p.e22062-e22062

2020

Link zum Volltext

Verfügbarkeit prüfen

Correction: Newly Diagnosed Glioblastoma in Elderly Patients

Current oncology reports, 2022-03, Vol.24 (3), p.387-387

2022

Link zum Volltext

Verfügbarkeit prüfen

Eyes and stroke: the visual aspects of cerebrovascular disease

Stroke and vascular neurology, 2017-12, Vol.2 (4), p.210-220

2017

Link zum Volltext

Verfügbarkeit prüfen

Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy

Immunotherapy, 2021-01, Vol.13 (1), p.11-17

2021

Link zum Volltext

Verfügbarkeit prüfen

Update on the evaluation of transient vision loss

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10 (Issue 1), p.297-303

2016

Link zum Volltext

Verfügbarkeit prüfen

Primary Ocular Adnexal Extranodal Marginal Zone Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Presenting as Orbital Apex Syndrome

Neuro-ophthalmology (Amsterdam : Aeolus Press. 1980), 2017-04, Vol.41 (2), p.94-98

2017

Link zum Volltext

Verfügbarkeit prüfen

Using the Theories of Joseph Babinski to Manage Functional Vision Loss

Cognitive and behavioral neurology, 2015-06, Vol.28 (2), p.46

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment for Primary Vitreoretinal Lymphoma: The Neuro-Oncologist’s View

Global Perspectives in Ocular Oncology, p.71-81

Link zum Volltext

Verfügbarkeit prüfen

Primary Ocular Adnexal Extranodal Marginal Zone Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Presenting as Orbital Apex Syndrome

Neuro-ophthalmology (Amsterdam : Aeolus Press. 1980), 2017-03, Vol.41 (2), p.94-98

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary Ocular Adnexal Extranodal Marginal Zone Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Presenting as Orbital Apex Syndrome

Neuro-ophthalmology (Aeolus Press), 2017, Vol.41 (2), p.94-98

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary Ocular Adnexal Extranodal Marginal Zone Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Presenting as Orbital Apex Syndrome

Neuro-Ophthalmology, 2017, Vol.41 (2), p.94-98

2017

Link zum Volltext

Verfügbarkeit prüfen

ATM mutation in a patient with thymoma‐associated myasthenia gravis

Muscle & nerve, 2020-08, Vol.62 (2), p.E50-E52

2020

Link zum Volltext

Verfügbarkeit prüfen

NCMP-10. DYSGRAPHIA AS THE EARLIEST PRESENTING SYMPTOM OF SEVERE CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY NEUROTOXICITY: A SINGLE CENTER EXPERIENCE

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi149-vi149

2021

Link zum Volltext

Verfügbarkeit prüfen

NIMG-06. BRAINSTEM NON-ENHANCING DIFFUSION-RESTRICTING T2 FLAIR HYPERINTENSITY AFTER EGFR TYROSINE KINASE INHIBITORS: AN EARLY SIGN OF LEPTOMENINGEAL DISEASE?

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v185-v185

2023

Link zum Volltext

Verfügbarkeit prüfen

IMMU-32. CAN PEMBROLIZUMAB TREAT RECURRENT GLIOBLASTOMA AND REVERSE HIV LATENCY?

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v149-v149

2023

Link zum Volltext

Verfügbarkeit prüfen

IMMU-51. NEUROLOGIC IMMUNE-RELATED ADVERSE EVENTS MIMICS, RISK FACTORS, AND MECHANISMS: CLIPPERS AND ASEPTIC MENINGITIS

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii115-ii116

2020

Link zum Volltext

Verfügbarkeit prüfen

NCMP-02. MYASTHENIA GRAVIS INDUCED BY AVELUMAB

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi179-vi179

2019

Link zum Volltext

Verfügbarkeit prüfen

Myasthenia gravis induced by avelumab

Immunotherapy, 2019-10, Vol.11 (14), p.1181-1185

2019

Link zum Volltext

Verfügbarkeit prüfen

PATH-32. CONCORDANCE FOR CDKN2A/B LOSS AND TERT MUTATION IN WHO 2021 CLASSIFICATION GRADE 3 MENINGIOMAS: A RETROSPECTIVE STUDY

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii157-vii157

2022

Link zum Volltext

Verfügbarkeit prüfen

NCOG-24. TIME TO FIRST RECURRENCE AND SURVIVAL IN IDH-WILDTYPE GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii202-vii202

2022

Link zum Volltext

Verfügbarkeit prüfen

Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study

Journal of immunotherapy (1997), 2019-04, Vol.42 (3), p.94

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(40)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear Palsy

Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept

Newly Diagnosed Glioblastoma in Elderly Patients

Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report

An atypical presentation of primary central nervous system lymphoma: A case report

Correction: Newly Diagnosed Glioblastoma in Elderly Patients

Eyes and stroke: the visual aspects of cerebrovascular disease

Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy

Update on the evaluation of transient vision loss

Primary Ocular Adnexal Extranodal Marginal Zone Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Presenting as Orbital Apex Syndrome

Using the Theories of Joseph Babinski to Manage Functional Vision Loss

Treatment for Primary Vitreoretinal Lymphoma: The Neuro-Oncologist’s View

Primary Ocular Adnexal Extranodal Marginal Zone Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Presenting as Orbital Apex Syndrome

Primary Ocular Adnexal Extranodal Marginal Zone Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Presenting as Orbital Apex Syndrome

Primary Ocular Adnexal Extranodal Marginal Zone Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Presenting as Orbital Apex Syndrome

ATM mutation in a patient with thymoma‐associated myasthenia gravis

NCMP-10. DYSGRAPHIA AS THE EARLIEST PRESENTING SYMPTOM OF SEVERE CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY NEUROTOXICITY: A SINGLE CENTER EXPERIENCE

NIMG-06. BRAINSTEM NON-ENHANCING DIFFUSION-RESTRICTING T2 FLAIR HYPERINTENSITY AFTER EGFR TYROSINE KINASE INHIBITORS: AN EARLY SIGN OF LEPTOMENINGEAL DISEASE?

IMMU-32. CAN PEMBROLIZUMAB TREAT RECURRENT GLIOBLASTOMA AND REVERSE HIV LATENCY?

IMMU-51. NEUROLOGIC IMMUNE-RELATED ADVERSE EVENTS MIMICS, RISK FACTORS, AND MECHANISMS: CLIPPERS AND ASEPTIC MENINGITIS

NCMP-02. MYASTHENIA GRAVIS INDUCED BY AVELUMAB

Myasthenia gravis induced by avelumab

PATH-32. CONCORDANCE FOR CDKN2A/B LOSS AND TERT MUTATION IN WHO 2021 CLASSIFICATION GRADE 3 MENINGIOMAS: A RETROSPECTIVE STUDY

NCOG-24. TIME TO FIRST RECURRENCE AND SURVIVAL IN IDH-WILDTYPE GLIOBLASTOMA

Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study

Suchergebnisse filtern